Anaplastic Oligodendroglioma (AO) Active Not Recruiting Phase 1 Trials for Ribociclib (DB11730)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03434262SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsTreatment